{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:45:03Z","timestamp":1787021103646,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":2168,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1194\/jlr.m050955","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T03:52:18Z","timestamp":1413431538000},"page":"2501-2508","source":"Crossref","is-referenced-by-count":83,"title":["Inflammation stimulates niacin receptor (GPR109A\/HCA2) expression in adipose tissue and macrophages"],"prefix":"10.1016","volume":"55","author":[{"given":"Kenneth R.","family":"Feingold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy K.","family":"Shigenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Grunfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M050955_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2796.2005.01528.x","article-title":"Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review","volume":"258","author":"Carlson","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1194\/jlr.M050955_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MOL.0b013e3282364add","article-title":"Niacin in cardiovascular prevention: mechanisms, efficacy, and safety","volume":"18","author":"Guyton","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.M050955_bib3","doi-asserted-by":"crossref","first-page":"20B","DOI":"10.1016\/j.amjcard.2008.02.029","article-title":"Mechanism of action of niacin","volume":"101","author":"Kamanna","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.M050955_bib4","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0021-9258(18)93503-9","article-title":"Effects of lipolytic and antilipolytic substances on adenosine 3\u2032,5\u2032-monophosphate levels in isolated fat cells","volume":"243","author":"Butcher","year":"1968","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M050955_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.0954-6820.1963.tb17457.x","article-title":"Studies on the effect of nicotinic acid on catecholamine stimulated lipolysis in adipose tissue in vitro","volume":"173","author":"Carlson","year":"1963","journal-title":"Acta Med. Scand."},{"key":"10.1194\/jlr.M050955_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm824","article-title":"PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect","volume":"9","author":"Tunaru","year":"2003","journal-title":"Nat. Med."},{"key":"10.1194\/jlr.M050955_bib7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1042\/bst0311120","article-title":"Molecular mechanisms regulating hormone-sensitive lipase and lipolysis","volume":"31","author":"Holm","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1194\/jlr.M050955_bib8","first-page":"139","article-title":"Cyclic AMP, PKA, and the physiological regulation of adiposity","volume":"53","author":"McKnight","year":"1998","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1194\/jlr.M050955_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0006-2952(02)01220-0","article-title":"G protein-coupled receptor for nicotinic acid in mouse macrophages","volume":"64","author":"Lorenzen","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1194\/jlr.M050955_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1124\/mol.59.2.349","article-title":"Characterization of a G protein-coupled receptor for nicotinic acid","volume":"59","author":"Lorenzen","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1194\/jlr.M050955_bib11","doi-asserted-by":"crossref","first-page":"14B","DOI":"10.1016\/j.amjcard.2008.02.028","article-title":"Niacin use and cutaneous flushing: mechanisms and strategies for prevention","volume":"101","author":"Davidson","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.M050955_bib12","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1172\/JCI23626","article-title":"GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing","volume":"115","author":"Beny\u00f3","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M050955_bib13","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1172\/JCI42273","article-title":"Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice","volume":"120","author":"Hanson","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M050955_bib14","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1172\/JCI27160","article-title":"Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid","volume":"115","author":"Pike","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M050955_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-291X(03)00342-5","article-title":"Molecular identification of nicotinic acid receptor","volume":"303","author":"Soga","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.M050955_bib16","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1074\/jbc.M210695200","article-title":"Molecular identification of high and low affinity receptors for nicotinic acid","volume":"278","author":"Wise","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M050955_bib17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tips.2006.05.008","article-title":"The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target","volume":"27","author":"Offermanns","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1194\/jlr.M050955_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/med.20102","article-title":"Nicotinic acid receptor subtypes and their ligands","volume":"27","author":"Soudijn","year":"2007","journal-title":"Med. Res. Rev."},{"key":"10.1194\/jlr.M050955_bib19","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1002\/1521-4141(200112)31:12<3714::AID-IMMU3714>3.0.CO;2-1","article-title":"PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily","volume":"31","author":"Schaub","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1194\/jlr.M050955_bib20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbrc.2012.07.082","article-title":"Effects of high fat diet on GPR109A and GPR81 gene expression","volume":"425","author":"Wanders","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.M050955_bib21","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1096\/fj.12-223933","article-title":"The role of HCA2 (GPR109A) in regulating macrophage function","volume":"27","author":"Zandi-Nejad","year":"2013","journal-title":"FASEB J."},{"key":"10.1194\/jlr.M050955_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.atherosclerosis.2009.08.045","article-title":"Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin","volume":"209","author":"Digby","year":"2010","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M050955_bib23","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.1073\/pnas.83.21.8313","article-title":"Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells","volume":"83","author":"Patton","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M050955_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1388-1981(99)00023-2","article-title":"Macrophage-targeted CTP:phosphocholine cytidylyltransferase (1\u2013314) transgenic mice","volume":"1437","author":"Tang","year":"1999","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M050955_bib25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","article-title":"TLR signaling","volume":"13","author":"Kawai","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1194\/jlr.M050955_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1753425908099317","article-title":"Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production via down-regulation of MyD88 expression","volume":"15","author":"Noman","year":"2009","journal-title":"Innate Immun."},{"key":"10.1194\/jlr.M050955_bib27","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1074\/jbc.M109.000414","article-title":"Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation","volume":"284","author":"Clark","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M050955_bib28","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1074\/jbc.273.3.1288","article-title":"Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta","volume":"273","author":"Hehner","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M050955_bib29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1189\/jlb.1111537","article-title":"Mechanisms of triglyceride accumulation in activated macrophages","volume":"92","author":"Feingold","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1194\/jlr.M050955_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MOL.0b013e32833cacd5","article-title":"Toll-like receptor-dependent lipid body formation in macrophage foam cell formation","volume":"21","author":"Nicolaou","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.M050955_bib31","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2013.06.008","article-title":"Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential","volume":"25","author":"Gaidarov","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1194\/jlr.M050955_bib32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI41651","article-title":"Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells","volume":"121","author":"Lukasova","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M050955_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bcp.2003.09.014","article-title":"Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin","volume":"67","author":"Rubic","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1194\/jlr.M050955_bib34","doi-asserted-by":"crossref","unstructured":".AIM-HIGH Investigators. 2011. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med., 365: 2255\u20132267.","DOI":"10.1056\/NEJMoa1107579"},{"key":"10.1194\/jlr.M050955_bib35","doi-asserted-by":"crossref","unstructured":"HPS2-THRIVE Collaborative Group. 2013. HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin\/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment. Eur. Heart J., 34: 1279\u20131291.","DOI":"10.1093\/eurheartj\/eht055"},{"key":"10.1194\/jlr.M050955_bib36","doi-asserted-by":"crossref","unstructured":".. HPS2-THRIVE Collaborative Group. 2014. Effects of extended-release niacin with laropiprant in high-risk patients. N. Engl. J. Med., 371: 203\u2013212.","DOI":"10.1056\/NEJMoa1300955"},{"key":"10.1194\/jlr.M050955_bib37","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520366906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520366906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M050955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T14:25:36Z","timestamp":1637418336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520366906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0022227520366906"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m050955","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}